Skip to main content
Top
Published in: Diabetologia 12/2017

Open Access 01-12-2017 | Article

Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy

Authors: Giovanni Ometto, Phil Assheton, Francesco Calivá, Piotr Chudzik, Bashir Al-diri, Andrew Hunter, Toke Bek

Published in: Diabetologia | Issue 12/2017

Login to get access

Abstract

Aims/hypothesis

Diabetic retinopathy is characterised by morphological lesions related to disturbances in retinal blood flow. It has previously been shown that the early development of retinal lesions temporal to the fovea may predict the development of treatment-requiring diabetic maculopathy. The aim of this study was to map accurately the area where lesions could predict progression to vision-threatening retinopathy.

Methods

The predictive value of the location of the earliest red lesions representing haemorrhages and/or microaneurysms was studied by comparing their occurrence in a group of individuals later developing vision-threatening diabetic retinopathy with that in a group matched with respect to diabetes type, age, sex and age of onset of diabetes mellitus who did not develop vision-threatening diabetic retinopathy during a similar observation period.

Results

The probability of progression to vision-threatening diabetic retinopathy was higher in a circular area temporal to the fovea, and the occurrence of the first lesions in this area was predictive of the development of vision-threatening diabetic retinopathy. The calculated peak value showed that the risk of progression was 39.5% higher than the average. There was no significant difference in the early distribution of lesions in participants later developing diabetic maculopathy or proliferative diabetic retinopathy.

Conclusions/interpretation

The location of early red lesions in diabetic retinopathy is predictive of whether or not individuals will later develop vision-threatening diabetic retinopathy. This evidence should be incorporated into risk models used to recommend control intervals in screening programmes for diabetic retinopathy.
Literature
1.
go back to reference Stitt AW, Curtis TM, Chen M et al (2016) The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 51:156–186CrossRefPubMed Stitt AW, Curtis TM, Chen M et al (2016) The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 51:156–186CrossRefPubMed
2.
go back to reference Bek T (2013) Regional morphology and pathophysiology of retinal vascular disease. Prog Retin Eye Res 36:247–259CrossRefPubMed Bek T (2013) Regional morphology and pathophysiology of retinal vascular disease. Prog Retin Eye Res 36:247–259CrossRefPubMed
3.
go back to reference Jensen PS, Jeppesen P, Bek T (2011) Differential diameter responses in macular and peripheral retinal arterioles may contribute to the regional distribution of diabetic retinopathy lesions. Graefes Arch Clin Exp Ophthalmol 249:407–412CrossRef Jensen PS, Jeppesen P, Bek T (2011) Differential diameter responses in macular and peripheral retinal arterioles may contribute to the regional distribution of diabetic retinopathy lesions. Graefes Arch Clin Exp Ophthalmol 249:407–412CrossRef
5.
go back to reference Hove MN, Kristensen JK, Lauritzen T, Bek T (2006) The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. Acta Ophthalmol Scand 84:619–623CrossRefPubMed Hove MN, Kristensen JK, Lauritzen T, Bek T (2006) The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. Acta Ophthalmol Scand 84:619–623CrossRefPubMed
6.
go back to reference Mehlsen J, Erlandsen M, Poulsen PL, Bek T (2012) Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol 90:109–114CrossRefPubMed Mehlsen J, Erlandsen M, Poulsen PL, Bek T (2012) Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol 90:109–114CrossRefPubMed
7.
go back to reference Bek T, Erlandsen M (2006) Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy. Acta Ophthalmol Scand 84:16–20CrossRefPubMed Bek T, Erlandsen M (2006) Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy. Acta Ophthalmol Scand 84:16–20CrossRefPubMed
8.
go back to reference Bek T, Jorgensen CM (2016) The systemic blood pressure and oxygen saturation in retinal arterioles predict the effect of intravitreal anti-VEGF treatment on diabetic maculopathy. Invest Ophthalmol Vis Sci 57:5429–5434CrossRefPubMed Bek T, Jorgensen CM (2016) The systemic blood pressure and oxygen saturation in retinal arterioles predict the effect of intravitreal anti-VEGF treatment on diabetic maculopathy. Invest Ophthalmol Vis Sci 57:5429–5434CrossRefPubMed
9.
go back to reference Hunter A, Lowell JA, Ryder B, Basu A, Steel D (2011) Automated diagnosis of referable maculopathy in diabetic retinopathy screening. Conf Proc IEEE Eng Med Biol Soc 2011:3375–3378PubMed Hunter A, Lowell JA, Ryder B, Basu A, Steel D (2011) Automated diagnosis of referable maculopathy in diabetic retinopathy screening. Conf Proc IEEE Eng Med Biol Soc 2011:3375–3378PubMed
10.
go back to reference Ometto G, Calivà F, Al-Diri B, Bek T, Hunter A (2016) Automated detection of retinal landmarks for the identification of clinically relevant regions in fundus photography. Proc. SPIE 9784, Medical Imaging 2016: Image Processing, 978429; doi:https://doi.org/10.1117/12.2216488 Ometto G, Calivà F, Al-Diri B, Bek T, Hunter A (2016) Automated detection of retinal landmarks for the identification of clinically relevant regions in fundus photography. Proc. SPIE 9784, Medical Imaging 2016: Image Processing, 978429; doi:https://​doi.​org/​10.​1117/​12.​2216488
11.
go back to reference Bek T, Jensen PK (1993) Three-dimensional structure of human retinal vessels studied by vascular casting. Acta Ophthalmol 71:506–513CrossRef Bek T, Jensen PK (1993) Three-dimensional structure of human retinal vessels studied by vascular casting. Acta Ophthalmol 71:506–513CrossRef
13.
go back to reference Rosenblatt M (1956) Remarks on some nonparametric estimates of a density function. The. Ann Math Stat 27:832–837CrossRef Rosenblatt M (1956) Remarks on some nonparametric estimates of a density function. The. Ann Math Stat 27:832–837CrossRef
14.
go back to reference Parzen E (1962) On estimation of a probability density function and mode. Ann Math Stat 33:1065–1076CrossRef Parzen E (1962) On estimation of a probability density function and mode. Ann Math Stat 33:1065–1076CrossRef
15.
go back to reference Efron B (1992) Bootstrap methods: another look at the jackknife. In: Kotz S, Johnson NL (eds) Breakthroughs in statistics. Springer, New York, pp 569–593CrossRef Efron B (1992) Bootstrap methods: another look at the jackknife. In: Kotz S, Johnson NL (eds) Breakthroughs in statistics. Springer, New York, pp 569–593CrossRef
16.
go back to reference Efron B (1987) Better bootstrap confidence intervals. J Am Stat Assoc 82:171–185CrossRef Efron B (1987) Better bootstrap confidence intervals. J Am Stat Assoc 82:171–185CrossRef
17.
go back to reference Bek T (1999) Diabetic maculopathy caused by disturbances in retinal vasomotion. A new hypothesis. Acta Ophthalmol Scand 77:376–380CrossRefPubMed Bek T (1999) Diabetic maculopathy caused by disturbances in retinal vasomotion. A new hypothesis. Acta Ophthalmol Scand 77:376–380CrossRefPubMed
18.
go back to reference Bek T (2011) Lack of correlation between short-term dynamics of diabetic retinopathy lesions and the arterial blood pressure. Graefes Arch Clin Exp Ophthalmol 249:267–271CrossRefPubMed Bek T (2011) Lack of correlation between short-term dynamics of diabetic retinopathy lesions and the arterial blood pressure. Graefes Arch Clin Exp Ophthalmol 249:267–271CrossRefPubMed
19.
go back to reference Hove MN, Kristensen JK, Lauritzen T, Bek T (2004) Quantitative analysis of retinopathy in type 2 diabetes: identification of prognostic parameters for developing visual loss secondary to diabetic maculopathy. Acta Ophthalmol Scand 82:679–685CrossRefPubMed Hove MN, Kristensen JK, Lauritzen T, Bek T (2004) Quantitative analysis of retinopathy in type 2 diabetes: identification of prognostic parameters for developing visual loss secondary to diabetic maculopathy. Acta Ophthalmol Scand 82:679–685CrossRefPubMed
20.
go back to reference Kohner EM, Patel V, Rassam SM (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44:603–607CrossRefPubMed Kohner EM, Patel V, Rassam SM (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44:603–607CrossRefPubMed
21.
go back to reference Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T (2006) The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 244:1255–1261CrossRefPubMed Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T (2006) The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 244:1255–1261CrossRefPubMed
22.
go back to reference Bek T, Helgesen A (2001) The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease. Acta Ophthalmol Scand 79:501–505CrossRefPubMed Bek T, Helgesen A (2001) The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease. Acta Ophthalmol Scand 79:501–505CrossRefPubMed
23.
go back to reference Mehlsen J, Erlandsen M, Poulsen PL, Bek T (2011) Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol 89:515–521CrossRefPubMed Mehlsen J, Erlandsen M, Poulsen PL, Bek T (2011) Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol 89:515–521CrossRefPubMed
Metadata
Title
Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy
Authors
Giovanni Ometto
Phil Assheton
Francesco Calivá
Piotr Chudzik
Bashir Al-diri
Andrew Hunter
Toke Bek
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 12/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4424-y

Other articles of this Issue 12/2017

Diabetologia 12/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.